Six Million Enrolled in New Medicare+Choice Plans

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 4
Volume 8
Issue 4

WASHINGTON-At the beginning of 1999, more than 6 million of Medicare’s 40 million beneficiaries were enrolled in some 300 Medicare+Choice plans, the new managed care program instituted by the Health Care Financing Administration (HCFA). The move to Medicare+Choice was not without disruption, as health care organizations covering 400,000 Medicare recipients refused to renew their contracts with HCFA under the new payment arrangement.

WASHINGTON—At the beginning of 1999, more than 6 million of Medicare’s 40 million beneficiaries were enrolled in some 300 Medicare+Choice plans, the new managed care program instituted by the Health Care Financing Administration (HCFA). The move to Medicare+Choice was not without disruption, as health care organizations covering 400,000 Medicare recipients refused to renew their contracts with HCFA under the new payment arrangement.

In the year 2000, payments for patients enrolled in Medicare+Choice plans will be determined by a combination of local and national rates, which will be adjusted to reflect the relative health status of the enrollees.

Recent Videos
Patients with cancer are subjected to fewer radiotherapy-induced toxicities because of newer, more advanced technologies.
Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.
Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
Receiving information regarding tumor-associated antigens or mutational statuses from biopsies may help treatment selection in GI malignancies.
An easy-to-access database allows one to see a patient’s cancer stage, prior treatment, and survival outcomes in a single place.
Related Content